Plymouth, United Kingdom · Founded 2018 · Privately Held (backing)
Developer of antimicrobial-resistant drugs designed to combat drug-resistant infections. Amprologix is based in Plymouth, United Kingdom and was founded in 2018. Its last reported valuation was $10.9 million in Oct 2025. It has raised $1 million.
Last reported valuation
$10.9M
Oct 2026
Priced at
—
Total raised
$1.0M
Last round
—
Team — not yet on record
No current team members for Amprologix are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Amprologix with a free account
·Watch Amprologix: the Monday email on marks, rounds and moves
